Alteral Therapeutics ApS
CIK: 0002026040
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NORD
Nordicus Partners Corp
10% Owner
Discretionary Trading P&L
Holdings
About Alteral Therapeutics ApS
Alteral Therapeutics ApS (SEC CIK 0002026040) files insider reports with the SEC as 10% Owner of Nordicus Partners Corp (NORD).
Signal8 holds 1 ownership filing by Alteral Therapeutics ApS, a Form 4, filed on Dec 10, 2024. Those filings report 1 transaction, the latest on Nov 12, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Alteral Therapeutics ApS's filings is in KLAMPENBORG, G7.
Recent filings by Alteral Therapeutics ApS
- Nov 12, 2024: Other transaction of NORD shares (Form 4, code J).
Other insiders filing for Nordicus Partners Corp (NORD)
- Rouf Henrik, Chief Executive Officer
- GK Partners ApS, 10% Owner
- AC Nordic ApS, 10% Owner
- ABCHill Holding ApS, 10% Owner
- Keller Henrik, Director
- Severin Bach Peter, Director